
Amarin Corporation PLC
AMRN · NASDAQ · Healthcare / Drug Manufacturers - General
Price History
Full chartMarket Stats
About
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - General
- CEOMr. Aaron D. Berg
- Employees80
- HeadquartersOne Central Plaza, Dublin, Ireland, D02 K7K5, USA
- Websitehttps://www.amarincorp.com
Leadership
- Mr. Aaron D. BergCEO, President & Director · b. 1963
- Mr. Peter L. FishmanSenior VP & CFO · b. 1984
- Dr. David Keenan Ph.D.Executive VP & Chief Operating Officer · b. 1968
- Dr. Steven B. Ketchum Ph.D.Executive VP, President of Research & Development and Chief Scientific Officer · b. 1965
- Mr. Jonathan N. ProvoostExecutive VP, Chief Legal & Compliance Officer and Secretary · b. 1970
- Mr. Eric BootheSenior Vice President of Corporate Development
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Hold1
- Sell2
Ownership Breakdown
- Institutions
- 20.78%
- Insiders
- 37.17%
- Retail / Other
- 42.05%
Top Institutional Holders
- Sarissa Capital Management LP1.67M7.92%
- Acadian Asset Management LLC636.77K3.01%
- Kynam Capital Management, LP532.98K2.52%
- Morgan Stanley - Brokerage Accounts293.17K1.39%
- Point72 Asset Management, L.P.240.76K1.14%
- Waterfront Wealth Inc.213.95K1.01%
- Brooklands Fund Management Limited177.32K0.84%
- Eversept Partners, LP145.30K0.69%
- Millennium Management LLC115.81K0.55%
- Two Sigma Investments LLC100.51K0.48%
- Citadel Advisors Llc95.36K0.45%
- BNP Paribas Arbitrage, SA75.50K0.36%
- LCM Capital Management, Inc51.36K0.24%
- Susquehanna International Group, LLP37.67K0.18%
- George Kaiser Family Foundation37.21K0.18%
- Arete Wealth Advisors, LLC26.91K0.13%
- State Street Corp24.95K0.12%
- Bleakley Financial Group LLC23.50K0.11%
- Renaissance Technologies Corp19.26K0.09%
Top Fund Holders
- Old Westbury Small & Mid Cap Strategies55.73K0.26%
Stock Splits
- Apr 11, 20251:20
- Jan 18, 20081:10
- Oct 19, 19981:10